Patents by Inventor Daniel Pinto

Daniel Pinto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOLOGICAL TISSUE AND METHOD OF MANUFACTURING
    Publication number: 20250269087
    Abstract: A processed adipose tissue is described, having an extracellular matrix derived from human adipose tissue and adipocyte cells having an intact adipocyte composition of at least 10%. A method of processing adipose tissue and a media loading tool are also described.
    Type: Application
    Filed: May 14, 2025
    Publication date: August 28, 2025
    Inventors: Oliver BURCKHARDT, Daniel PINTO, Laura Bordallo CASTILLO, Andrey AGASHCHUK
  • Regulatory sequences of the mouse villin gene—use in transgenesis
    Patent number: 7067648
    Abstract: The invention relates to regulatory sequences of the mouse villin gene that efficiently drive transgenic expression in immature and differentiated epithelial cells of the intestine and uro-genital tracts. The invention also relates to recombinant constructs comprising said regulatory sequences, for the control of the targeted expression of determined nucleic acid sequences so-called (heterologous sequences or also transgenes), in cells or tissues originating from the intestinal mucosa. A further object of the invention is to provide cells, tissues or organisms including animals, expressing said determined nucleic acid sequences in a targeted manner.
    Type: Grant
    Filed: June 8, 2001
    Date of Patent: June 27, 2006
    Assignees: Institut Curie, Centre National de la Recherche and Scientifique
    Inventors: Daniel Pinto, Sylvie Robine, Frédéric Jaisser, Daniel Louvard
  • Regulatory sequences of the mouse villin gene - use in transgenesis
    Publication number: 20020102705
    Abstract: The invention relates to regulatory sequences of the mouse villin gene that efficiently drive transgenic expression in immature and differentiated epithelial cells of the intestine and uro-genital tracts. The invention also relates to recombinant constructs comprising said regulatory sequences, for the control of the targeted expression of determined nucleic acid sequences so-called (heterologeous sequences or also transgenes), in cells or tissues originating from the intestinal mucosa. A further object of the invention is to provide cells, tissues or organisms including animals, expressing said determined nucleic acid sequences in a targeted manner.
    Type: Application
    Filed: June 8, 2001
    Publication date: August 1, 2002
    Inventors: Daniel Pinto, Sylvie Robine, Frederic Jaisser, Daniel Louvard